228 related articles for article (PubMed ID: 28302417)
1. MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.
Rajabi H; Kufe D
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):117-122. PubMed ID: 28302417
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
Bouillez A; Rajabi H; Jin C; Samur M; Tagde A; Alam M; Hiraki M; Maeda T; Hu X; Adeegbe D; Kharbanda S; Wong KK; Kufe D
Oncogene; 2017 Jul; 36(28):4037-4046. PubMed ID: 28288138
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
Rajabi H; Hiraki M; Kufe D
Oncogene; 2018 Apr; 37(16):2079-2088. PubMed ID: 29379165
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.
Li W; Han Y; Sun C; Li X; Zheng J; Che J; Yao X; Kufe D
Theranostics; 2022; 12(3):999-1011. PubMed ID: 35154471
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells.
Rajabi H; Tagde A; Alam M; Bouillez A; Pitroda S; Suzuki Y; Kufe D
Oncogene; 2016 Dec; 35(50):6439-6445. PubMed ID: 27212035
[TBL] [Abstract][Full Text] [Related]
6. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.
Gnemmi V; Bouillez A; Gaudelot K; Hémon B; Ringot B; Pottier N; Glowacki F; Villers A; Vindrieux D; Cauffiez C; Van Seuningen I; Bernard D; Leroy X; Aubert S; Perrais M
Cancer Lett; 2014 May; 346(2):225-36. PubMed ID: 24384091
[TBL] [Abstract][Full Text] [Related]
7. Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
Zhang L; Ma T; Brozick J; Babalola K; Budiu R; Tseng G; Vlad AM
Oncogene; 2016 Sep; 35(38):5010-20. PubMed ID: 26973247
[TBL] [Abstract][Full Text] [Related]
8. MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.
Alam M; Ahmad R; Rajabi H; Kufe D
Mol Cancer Res; 2015 Mar; 13(3):449-60. PubMed ID: 25368430
[TBL] [Abstract][Full Text] [Related]
9. IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1.
Liao G; Wang M; Ou Y; Zhao Y
Cell Signal; 2014 Oct; 26(10):2131-7. PubMed ID: 24971507
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
12. miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.
Jin C; Rajabi H; Kufe D
Int J Oncol; 2010 Jul; 37(1):61-9. PubMed ID: 20514397
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.
Kufe DW
Carcinogenesis; 2020 Sep; 41(9):1173-1183. PubMed ID: 32710608
[TBL] [Abstract][Full Text] [Related]
14. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
15. Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells.
Kufe DW
J Cancer Metastasis Treat; 2022; 8():. PubMed ID: 35539431
[TBL] [Abstract][Full Text] [Related]
16. ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1.
Horn G; Gaziel A; Wreschner DH; Smorodinsky NI; Ehrlich M
Exp Cell Res; 2009 May; 315(8):1490-504. PubMed ID: 19245809
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
18. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
[TBL] [Abstract][Full Text] [Related]
19. MUC1: a multifaceted oncoprotein with a key role in cancer progression.
Nath S; Mukherjee P
Trends Mol Med; 2014 Jun; 20(6):332-42. PubMed ID: 24667139
[TBL] [Abstract][Full Text] [Related]
20. Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.
Zhou Y; Rajabi H; Kufe D
Mol Pharmacol; 2011 May; 79(5):886-93. PubMed ID: 21346142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
